Memantine LEK
Država: Europska Unija
Jezik: portugalski
Izvor: EMA (European Medicines Agency)
Uputa o lijeku
(PIL)
16-11-2020
Svojstava lijeka
(SPC)
16-11-2020
Izvješće o ocjeni javnog
(PAR)
29-04-2013
Aktivni sastojci:
cloridrato de memantina
Dostupno od:
Pharmathen S.A.
ATC koda:
N06DX01
INN (International ime):
memantine
Terapijska grupa:
Psychoanaleptics, , Outros anti-demência drogas
Područje terapije:
Doença de Alzheimer
Terapijske indikacije:
Tratamento de pacientes com doença de Alzheimer moderada a grave.
Proizvod sažetak:
Revision: 5
Status autorizacije:
Autorizado
Datum autorizacije:
2013-04-21
Uputa o lijeku
Skip to main content [European Medicines Agency]
Menu *
EMA WEBSITE TEMPORARILY UNAVAILABLE
This website is currently unavailable due to essential maintenance.
EMERGENCY CONTACT DETAILS
To report a potentially serious problem with a centrally authorised
medicine, call our product emergency hotline on +31 (0)88 781 7600.
To report a product quality defect, including a suspected defect, of a
centrally authorised medicine that could result in a recall or
abnormal restriction on supply, marketing or manufacturing
authorisation holders can call +31 (0)65 008 9457 outside business
hours.
The details of your call may be documented, including personal data if
you provide them (such as your name, contact details and nature of the
issue raised), in accordance with our privacy statement. You can
consult our privacy statement at
https://www.ema.europa.eu/en/about-us/legal/general-privacy-statement
[/en/about-us/legal/general-privacy-statement] once the website is
back online.
RSS feed Twitter YouTube LinkedIn
© 1995-2020 European Medicines Agency
European Union agencies network [European Union agencies network]
An agency of the European Union [European Union flag]
Pročitajte cijeli dokument
Svojstava lijeka
Skip to main content [European Medicines Agency]
Menu *
EMA WEBSITE TEMPORARILY UNAVAILABLE
This website is currently unavailable due to essential maintenance.
EMERGENCY CONTACT DETAILS
To report a potentially serious problem with a centrally authorised
medicine, call our product emergency hotline on +31 (0)88 781 7600.
To report a product quality defect, including a suspected defect, of a
centrally authorised medicine that could result in a recall or
abnormal restriction on supply, marketing or manufacturing
authorisation holders can call +31 (0)65 008 9457 outside business
hours.
The details of your call may be documented, including personal data if
you provide them (such as your name, contact details and nature of the
issue raised), in accordance with our privacy statement. You can
consult our privacy statement at
https://www.ema.europa.eu/en/about-us/legal/general-privacy-statement
[/en/about-us/legal/general-privacy-statement] once the website is
back online.
RSS feed Twitter YouTube LinkedIn
© 1995-2020 European Medicines Agency
European Union agencies network [European Union agencies network]
An agency of the European Union [European Union flag]
Pročitajte cijeli dokument
